These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. When is thrombolysis justified in patients with acute ischemic stroke? Rosenblum WI Stroke; 1997 May; 28(5):1086-7. PubMed ID: 9158655 [No Abstract] [Full Text] [Related]
9. [Thrombolysis in acute stroke with tissue plasminogen activator]. Willig V; Hacke W Dtsch Med Wochenschr; 1996 Mar; 121(13):A8-A10. PubMed ID: 8681730 [No Abstract] [Full Text] [Related]
10. Thrombolysis for acute stroke: a new era in treatment. Gress DR; Bonovich D Am Fam Physician; 1997 Jun; 55(8):2590-1. PubMed ID: 9191443 [No Abstract] [Full Text] [Related]
11. Intravenous thrombolytic therapy for acute ischemic stroke. Weighing the risks and benefits of tissue plasminogen activator. Koller RL; Anderson DC Postgrad Med; 1998 Apr; 103(4):221-4, 229-31. PubMed ID: 9553597 [TBL] [Abstract][Full Text] [Related]
19. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451 [TBL] [Abstract][Full Text] [Related]
20. Results of American and European studies of thrombolysis in acute stroke are not conflicting. Bruno A BMJ; 1997 Jan; 314(7073):76. PubMed ID: 9001508 [No Abstract] [Full Text] [Related] [Next] [New Search]